(19)

(11)

EP 4 770 671 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24861011.5 (22) Date of filing: 29.08.2024

(51) International Patent Classification (IPC):  A61K 39/42(2006.01) C07K 16/10(2026.01) A61P 31/18(2006.01) (52) Cooperative Patent Classification (CPC): A61P 31/18; C07K 2317/21; C07K 2317/76; C07K 2317/33; C07K 2317/565; C07K 2317/30; C07K 2317/34; C07K 2317/35; C07K 2317/92; C07K 16/114; C07K 16/1145 (86) International application number: PCT/US2024/044375 (87) International publication number: WO 2025/049708 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 31.08.2023 US 202363535669 P (71) Applicant: International Aids Vaccine Initiative New York, NY 10004 (US)	(72) Inventors: LANDAIS, Elise New York, New York 10004 (US) SOK, Devin New York, New York 10004 (US) (74) Representative: Buzzi, Notaro & Antonielli d'Oulx S.p.A.  Corso Vittorio Emanuele II, 6 10123 Torino 10123 Torino (IT)